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Management of endoleak after endovascular
aneurysm repair: Cuffs, coils, and conversion
Peter L. Faries, MD,a Hadley Cadot, MD,b Gautam Agarwal, MD,a K. Craig Kent, MD,a Larry H.
Hollier, MD,b and Michael L. Marin, MD,b New York, NY
Objective: The effectiveness of endovascular treatment of abdominal aortic aneurysm (AAA) may be limited by persistent
perfusion of the aneurysm sac (endoleak). Endoleak that results in persistent systemic pressurization of the aneurysm or
in continued AAA expansion is believed to require treatment to prevent rupture. This report describes the results of three
techniques used to treat endoleak.
Methods: Endovascular repair of AAA was performed in 597 patients between January 1996 and September 2002.
Seventy-three endoleaks that required treatment developed in 70 patients (11.7%). These involved the graft attachment
site (type I) or the graft junction site (type III) or originated from collateral side-branch vessels (type II) and were
associated with an increase in aneurysm size. Endoleak type was confirmed at angiography in all cases. Average time
between the initial endovascular procedure and endoleak treatment was 14.5  5.7 months. The techniques used for
endoleak treatment were deployment of an endovascular extension graft or cuff (n 44), coil embolization (n 24,) and
conversion to conventional open repair (n 5). Configurations of endovascular grafts in which endoleak developed were
bifurcated (n 44), aortouniiliac (n 15), and aortoaortic-tube (n 11). Mean follow-up after endoleak treatment was
24.5  12.2 months (range, 1-60 months).
Results: Endovascular extension grafts or cuffs were used to treat 41 attachment site endoleaks and 3 graft junction
endoleaks, with overall technical success rate of 97%. Embolic coils were used to treat 16 retrograde side-branch endoleaks
and 8 attachment site endoleaks, with overall technical success rate of 87%. Conversion to open surgery was performed in
4 patients with attachment site endoleaks and 1 patient with a graft junction site endoleak, and was successful in all cases.
After endoleak treatment, aneurysm size decreased (>5 mm) in 38% of patients, stabilized in 58% of patients, and
increased (>5 mm) in 4% of patients. Major morbidity occurred in 7.0%, with no perioperative deaths.
Conclusions: Endovascular extension grafts, coil embolization, and conversion to open surgery each may be used to
effectively repair endoleak. Selection of the treatment method used is determined by the anatomic characteristics of the
endoleak and the patient’s ability to tolerate conventional repair. Conversion to open repair was uniformly successful.
Deployment of an extension cuff was successful when complete closure of the endoleak was achieved. Embolic coils were
effective for retrograde endoleaks and provided stabilization of AAA size in selected patients with attachment site
endoleaks in limited follow-up. (J Vasc Surg 2003;37:1155-61.)
The use of endovascular stent grafts to prevent rup-
ture of abdominal aortic aneurysm (AAA) is predicated
on elimination of arterial perfusion from the aneurysm
sac. Exclusion of the AAA from the arterial circulation
eliminates arterial pressure and thereby prevents aneu-
rysm growth and rupture.1 Continued arterial perfusion
of the aneurysm sac may occur, however, after endovas-
cular AAA repair. This persistent perfusion has been
termed “endoleak”2 and has been observed in 15% to
21% of clinical trials involving commercially produced
endovascular stent grafts.3-10
Endoleaks have been classified into types on the basis of
the etiology or site of origin.11,12 Endoleaks that result in
direct antegrade flow into the aneurysm sac may occur at
the endovascular stent graft attachment site (type I) or at
the junction point between graft components (type III).
These direct antegrade endoleaks are associated with con-
siderable risk for aneurysm rupture and therefore necessi-
tate prompt and definitive treatment.13,14 Endoleaks may
also originate through retrograde flow in the collateral
side-branch arteries of the aneurysm (type II). The most
common vessels involved are the lumbar and inferior mes-
enteric arteries. The force generated by this retrograde
collateral perfusion has been difficult to quantify.15 How-
ever, aneurysm rupture has been reported to result from
type II endoleak.16 Many investigators therefore recom-
mend treatment, particularly when type II endoleak is
associated with AAA expansion.17 Management of both
direct (type I and III) and collateral (type II) endoleaks is
an essential element of endovascular treatment of AAA.18
This report describes results of three techniques used to
treat endoleak.
From the Division of Vascular Surgery, Department of Surgery, New York
Presbyterian Hospital, Weill-Cornell Medical School, New York, NY and
Mount Sinai School of Medicine, New York, NY.
Competition of interest: none.
Presented at the Thirtieth Annual Meeting of the New England Society for
Vascular Surgery, Rockport, Me, Oct 4-6, 2002.
Reprint requests: Peter L. Faries, MD, Division of Vascular Surgery, Depart-
ment of Surgery, New York Presbyterian Hospital, Weill-Cornell Medical
School, 525 E 68th St, Rm P705, New York, NY 10021. (e-mail:
plf2001@med.cornell.edu).
Copyright © 2003 by The Society for Vascular Surgery and The American





Patient demographics and database. Five hundred
ninety-seven patients underwent endovascular repair of
AAA between January 1996 and September 2002 under
protocol approved by the Institutional Review Board of
Mount Sinai Medical Center and Weill-Cornell Medical
School. Seventy-three endoleaks that required treatment
developed in 70 patients (11.4%). The endoleaks were
localized to the proximal attachment site in 41 cases and the
distal attachment site in 12 cases. The endovascular stent
graft junction was the source of the endoleak in four cases.
Endoleaks originated from collateral lumbar or inferior
mesenteric arteries or both in 16 cases (Table I).Maximum
aortic diameter at endoleak treatment ranged from 5.9 to
8.2 cm (mean, 6.4 cm).
Endovascular stent grafts used for the initial AAA repair
that developed endoleaks were Talent (Medtronic World
Medical, Sunrise, Fla; n  51), physician-made (n  6),
AneuRx (Medtronic/AVE, Santa Rosa, Calif; n  6),
Vanguard (Meditech/Boston Scientific, Natick, Mass; n
3), Excluder (WL Gore, Flagstaff, Ariz; n  2), Lifepath
(Baxter, Deerfield, Ill; n 1), and Ancure (Guidant, Menlo
Park, Calif; n  1). There was no significant relationship
between type of graft used and incidence of endoleak. The
configurations of these grafts were bifurcated (n  44),
aortouniiliac (n  15), and aortoaortic (n  11). Grafts
that developed distal attachment site endoleaks were Talent
(n  6), physician-made (n  3), and Vanguard (n  2).
Average time between primary endovascular AAA repair
and the procedure to treat the endoleak was 14.5  5.7
months. Time between initial AAA repair and endoleak
treatment was significantly longer for type II endoleaks
than for type I and III endoleaks (12.3 4.2 vs 5.79 7.8;
P  0.01). All data for each patient, procedure, and fol-
low-up were entered prospectively in a computerized vas-
cular registry. Each of the 68 patients had concomitant
comorbid medical conditions (average, 2.7 per patient)
(Table II). The incidence of comorbid medical conditions
was similar to that for the overall patient population under-
going endovascular procedures.
Preoperative management. Preoperative assessment
included helical computed tomography angiography
(CTA) with intravenous contrast medium, with images
acquired at 3 mm intervals. The scans were used to
determine the presence of an endoleak and to measure
aneurysm size. Video image analysis software (Fiesta;
General Electric Medical Systems, Milwaukee, Wis) was
used to calculate change in AAA size. CTA was also used
to direct subsequent angiography for endoleak localiza-
tion. Site of origin of the endoleak was confirmed with
digital subtraction angiography in all 73 cases.
Endovascular extension graft and cuff pro-
cedure. All endovascular extension graft procedures were
performed in the operating room on a radiolucent table
with fluoroscopic guidance. Epidural or spinal anesthetic
was used in all patients. Exposure of the common femoral
and distal external iliac arteries was performed through an
oblique groin incision.19 The Talent endovascular stent
graft was used for correction of all but 2 of the proximal
attachment site endoleaks that were treated with placement
of an extension graft or cuff (Fig 1); the remaining two
endoleaks were treated with AneuRx proximal cuff exten-
sions. This allowed for transrenal fixation in patients who
received Talent grafts. The aortoaortic tube or cuff config-
uration was used most commonly for treatment of proximal
endoleaks (n  24), whereas aortouniiliac grafts were re-
quired infrequently (n 6). Endovascular extension grafts
used for repair of distal attachment site and graft junction
site endoleaks were Talent (n 11), Vanguard (n 2), and
AneuRx (n  1). The aortouniiliac configuration was used
to treat 9 distal endoleaks, and the bifurcated configuration
was used to treat 2 endoleaks. Two graft junction endoleaks
were repaired with ilioiliac grafts, and 1 was repaired with
an aortouniiliac graft.
Coil embolization procedure Coil embolization was
performed transluminally through percutaneous arterial ac-
cess in all 24 patients. Embolic coils (Cook Vascular,
Bloomington, Ind) were deployed in the collateral vessel at
Table II. Patient demographic data and comorbid
illnesses
Characteristic Number Percent
Male gender 60 86
Hypertension requiring medication 47 67
Coronary artery disease 22 31
Chronic obstructive pulmonary disease 7 10
Hypercholesterolemia 7 10
Renal insufficiency (creatine 1.4) 4 6
Diabetes (type I and II) 3 4
Stroke or transient ischemic attack 1 1
History of recent (within 3 months) smoking 41 59
Average age (y) 76.4











Extension endograft 30 11 0 3
Coil embolization 7 1 16 0
Conversion to open repair 4 0 0 1
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Fig 1. Digital subtraction angiogram of proximal attachment site endoleak treatment. A, On lateral projection,
extensive proximal attachment site endoleak is seen originating along the posterior aortic wall (arrow). B, Selective
interrogation confirms location from which the endoleak originates. C, After deployment, extension cuff (arrow) is
visualized proximal to the original stent graft. D, Completion angiogram confirms elimination of perfusion of the
aneurysm with deployment of the proximal extension graft. Marker on the extension cuff (arrow) indicates that the
proximal extent of the graft material has been positioned immediately distal to the renal arteries.
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its origin from the aneurysm sac in all cases. Endoleaks
emanating from the inferior mesenteric artery were ac-
cessed through collateral vessels originating from the supe-
rior mesenteric artery. Lumbar artery endoleaks were em-
bolized through collateral vessels accessed from the
iliolumbar or circumflex iliac arteries (Fig 2). Endoleaks
were found to have 2 contributing collateral vessels in 6 of
the 16 patients with type II endoleaks. Coil embolization of
both vessels was performed in these six cases. In the remain-
ing 10 patients only a single collateral feeding vessel was
visualized. In the eight patients who underwent coil embo-
lization of attachment site endoleaks, adequate length of
undilated artery that would allow deployment of an endo-
vascular extension graft was not present. In addition, these
patients were at high risk for conventional open repair. In
these patients the origin of the endoleak at the attachment
site was interrogated directly from the aortic lumen. Em-
bolic coils were then placed into the aneurysm sac until
cessation of flow into the aneurysm was obtained.
Conversion to standard open repair. Conversion to
open repair was performed in five patients in whom the
anatomy of the attachment site endoleak or graft junction
endoleak precluded placement of an endovascular exten-
sion graft. Conversion was delayed in 4 patients and imme-
diately at the initial endovascular procedure in 1 patient. All
patients had limited comorbid medical conditions and were
determined by medical evaluation to be adequate candi-
dates for conventional surgery. Conversion was performed
Fig 2. Digital subtraction angiogram of collateral branch endoleak treatment. A, Flush aortogram demonstrates that
the type II endoleak originates from collateral communication between the circumflex iliac and lumbar arteries (arrow).
B, Selective injection of the lumbar artery demonstrates contrast material collecting in the aneurysm sac (arrow),
confirming location of the endoleak. C, Cessation of aneurysm perfusion is seen after deployment of embolic coils
(arrow) at site of origin of the lumbar artery from the aneurysm sac.
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through the transabdominal approach in all cases. Tempo-
rary control of the aorta in the supraceliac position20 was
used in 4 of 5 patients, to facilitate extraction of the stent
graft, with subsequent replacement of the clamp in the
infrarenal position.
Postoperative monitoring and follow-up. After re-
pair of the endoleak, all patients were enrolled in a standard
follow-up protocol that included office visits within 1
month of surgery, at 6 and 12 months postoperatively, and
annually thereafter. During the visit a detailed history was
obtained and physical examination was performed. Plain
radiographs of the abdomen and a contrast-enhanced heli-
cal computed tomography scan were also obtained at these
follow-up visits. Mean follow-up was 24.5  12.2 months
after endoleak repair.
Definitions and statistical analysis. Definitions used
are those outlined by the Ad Hoc Committee on Reporting
Standards, Society for Vascular Surgery/American Associ-
ation for Vascular Surgery.21 All values represent mean 
SD. The Student t test was used to compare continuous
variables. Significance was assumed at P  .05.
RESULTS
Technical success. Endovascular extension grafts or
cuffs were successfully deployed in all 44 patients. In 1
patient a proximal attachment site endoleak (type I) per-
sisted after endograft deployment (98% initial technical
success), and ultimately conversion to conventional open
repair was required. Two of 16 patients who had under-
gone coil embolization of type II collateral branch en-
doleaks had persistent type II endoleaks (87% initial tech-
nical success). Repeat angiography was successful in
localizing the newly visualized collateral vessel from which
the endoleak originated, and a second coil embolization
procedure was performed in each case. Conversion to open
surgical repair was successful in all 5 cases in which it was
performed. Coils were also successfully deployed into the
aneurysm sac in 8 of 8 patients with attachment site en-
doleaks treated with coil embolization.
Aneurysm size. Maximum aortic diameter decreased
by 5 mm or more in 38% of patients after repair of the
endoleak (42% of cuff extension procedures, 31% of type II
endoleaks). Maximum aortic diameter remained stable
(change  5 mm) in 58% of patients after endoleak treat-
ment, and maximum aneurysm size increased by 5 mm or
more in 4% of patients. Overall mean reduction in maxi-
mum aortic diameter was 5.1 mm in patients who received
an endovascular extension cuff. Mean maximum diameter
decreased by 3.3 mm in patients who underwent coil
embolization. Reduction in maximum aortic diameter was
noted in only 1 of 8 patients with type I endoleaks treated
with coil embolization, although stabilization was observed
in the remaining 7 patients.
Secondary procedures. One patient underwent con-
version to open surgical repair 1 month after deployment of
an endovascular extension graft and cuff failed to seal a
proximal attachment site endoleak. Repeated coil emboli-
zation was performed in 2 patients, 6 and 12 months,
respectively, after initial type II endoleak treatment, be-
cause of newly visualized type II endoleaks. In 2 patients
the iliac endovascular graft limb became occluded after
secondary repair and required extraanatomic revasculariza-
tion.
Morbidity and mortality. There were no 30-day
perioperative deaths (0%) after endoleak repair procedures.
Total 30-day major morbidity rate was 6.8% (Table III-
),and total 30-day minor morbidity rate was 5.5% (Table
IV).No significant difference in perioperative morbidity
and mortality was present between open conversion and
endovascular repair groups.
DISCUSSION
Clinical trials using endovascular stent grafts for treat-
ment of AAA consistently demonstrate a significant inci-
dence of endoleak.3-10 These endoleaks compromise over-
all effectiveness of aneurysm repair. While the precise
parameters that define the need for intervention to correct
endoleak have not been definitively established, occurrence
of aneurysm expansion and rupture associated with un-
treated endoleak confirms the need for correction in certain
cases.13,14,16,17,22
A variety of techniques have been used to treat en-
doleak. Early reports describe conversion from endovascu-
lar to conventional open aneurysm repair.23,24 Conversion
has been performed both during endovascular surgery and
later in a relatively elective fashion.25 Conversion to con-
ventional open repair is associated with significant compli-
cations.26,27 Some have related to the need for urgent
conversion. In addition, endovascular repair is frequently
selected for patients with significant comorbid medical
illnesses. These patients are often less well able to tolerate
open surgical repair. As a result, morbidity and mortality
that exceed rates typically reported for elective conven-
tional repair have been observed.23-28 Difficulties associ-
Table III. Major morbidity and mortality
Morbidity Number Percent
Systemic




Congestive heart failure 1 1.4
Anatomic
Limb occlusion 2 2.8
Total 5 6.8
30-day mortality 0




Superficial wound infection 1 1.4
Total 4 5.5
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ated with the presence of a stent graft within the aneurysm
itself have also been noted. In particular, problems obtain-
ing proximal aortic control and in removing devices with
transmural fixation barbs have been described.23
Additional techniques more recently used to treat en-
doleak include placement of a secondary endovascular stent
graft extension or cuff, and coil embolization of either
collateral arteries feeding the aneurysm sac or of the sac
itself. Other techniques that have been proposed include
direct induction of aneurysm thrombosis with injection of
thrombin-polymer, placement of a thrombogenic sponge,
laparoscopic ligation of the feeding lumbar artery, and
deployment of a Palmaz stent at the proximal implantation
site.
In this study the technique selected for treatment was
determined primarily by the cause of the endoleak or its
anatomic site. Placement of a secondary endovascular ex-
tension graft for treatment of an attachment site or graft
junction leak was performed whenever technically feasible.
Use of an endovascular extension graft required that an
adequate length of undilated artery be present in the region
adjoining the attachment site endoleak. Proximal neck
anatomy was of particular significance in endoleaks origi-
nating at the proximal aortic attachment site, where the
level of the renal artery ostia may be a significantly limiting
factor. In the current study transrenal fixation with a cus-
tom-fabricated Talent extension graft was used for all prox-
imal site failures, to provide increased fixation of the endo-
vascular extension graft. As a result, no difficulty was
encountered with limited space between the renal arteries
and the graft flow divider. Proximal extension cuffs or grafts
were routinely oversized by 2 to 4 mm.
Endoleaks originating at the distal aortic attachment
site occurred in 11 study patients who had undergone
primary AAA repair with an aortoaortic tube graft. Graft
migration in these cases occurred; however, it appeared to
be a consequence of aortic neck dilatation, as was the case
for proximal attachment site endoleaks. Extension to the
iliac artery with an aortouniiliac or bifurcated stent graft
was required in these patients. Bifurcated grafts were used
when sufficient space was present to allow the contralateral
limb of a bifurcated device to be cannulated and deployed.
The aortouniiliac configuration was used in the remaining
cases. Oversizing of the iliac implantation site by 2 mm
likely accounts for the absence of iliac endoleaks. In treating
endoleaks that originated from a defect at the graft junction
site, it was first necessary to cross the defect with an angio-
graphic wire. This allowed the endovascular graft to tra-
verse the defect, sealing the endoleak. In 1 patient in whom
the defect could not be crossed with the angiographic wire,
conversion to open surgical repair was required.
Transcatheter coil embolization was used preferentially
to treat endoleaks originating from collateral branches of
the aneurysm sac. Translumbar coil embolization was not
used. In 6 of 16 patients with type II endoleaks, two arteries
combined to generate the endoleak. It is possible that the
presence of two patent collateral arteries that allow both
inflow and outflow from the aneurysm sac contributed to
the persistence of the type II endoleaks in these cases.29,30
Coil embolization was successful in eliminating aneurysm
perfusion in most cases. However, the durability of this
technique for endoleak repair has been questioned.31,32 In
the current study, development or unmasking of a second
type II endoleak occurred in two patients at subsequent
follow-up, and repeated embolization was necessary. Fur-
ther follow-up will be necessary to accurately assess the
long-term effectiveness of coil embolization for treatment
of collateral branch endoleaks.
In eight highly selected patients, coil embolization was
also used to treat attachment site endoleaks. In each case no
adequate site for implantation was present that would allow
use of an extension graft or cuff. All eight patients also had
extensive comorbid medical conditions that precluded con-
version to conventional repair. Direct coil embolization of
the aneurysm sac has been reported to be successful in
treatment of type II endoleaks.31 After coil embolization,
aneurysm size has not increased in any patients in the
current study, which may suggest stabilization. However,
reduction in aneurysm diameter has been observed in only
1 of 8 patients. In addition, studies conducted in animal
models of AAA suggest that coil embolization of type I
endoleak does not effectively reduce intra-aneurysmal pres-
sure.33 Follow-up has been 1 year or less in 7 of 8 of these
patients. In this study the use of coil embolization to treat
attachment site endoleaks was limited to patients in whom
no alternative treatment was available.
Localization of the source of the endoleak is essential for
successful treatment.34,35 In this study CTA was effective as a
screening method, providing accurate information regarding
change in aneurysm size and suggesting the likely source of
the endoleak. However, definitive determination of the source
of the endoleak required angiography in several cases. Once
the source of the endoleak was confirmed, the treatment
method was selected. Cuff extension was used preferentially
for attachment site and graft junction endoleaks; coil emboli-
zation was selected for type II endoleaks. Endoleaks were
determined to originate from a combination of type I and II
endoleaks in 3 patients at angiography. Spontaneous resolu-
tion of the type II endoleak occurred after treatment of the
type I endoleak with an endovascular extension graft in these
patients. These findings suggest that ongoing follow-up of
these patients is important.
CONCLUSION
In repairing endoleaks, endovascular cuff extension, coil
embolization, and conversion to conventional surgery each
may be used effectively. Selection of the treatment method
used for correction is determined by the anatomic character-
istics of the endoleak and overall patient health. Deployment
of an extension cuff was successful when complete closure of
the endoleak was achieved. Embolic coils were effective for
retrograde endoleaks, and they provided stabilization of AAA
size in selected patients with attachment site endoleaks in
limited follow-up. Conversion to open repair was uniformly
successful in treating endoleaks, but was used only in patients
without extensive comorbid conditions. Careful continued
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follow-up will be necessary to determine the long-term effec-
tiveness of each of these techniques.
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